These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 7538501

  • 1. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma.
    Montemaggi P, Costamagna G, Dobelbower RR, Cellini N, Morganti AG, Mutignani M, Perri V, Brizi G, Marano P.
    Int J Radiat Oncol Biol Phys; 1995 May 15; 32(2):437-43. PubMed ID: 7538501
    [Abstract] [Full Text] [Related]

  • 2. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?
    Montemaggi P, Morganti AG, Dobelbower RR, Brizi G, Smaniotto D, Costamagna G, Cellini N, Marano P.
    Radiology; 1996 Jun 15; 199(3):861-6. PubMed ID: 8638018
    [Abstract] [Full Text] [Related]

  • 3. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
    Mutignani M, Shah SK, Morganti AG, Perri V, Macchia G, Costamagna G.
    Endoscopy; 2002 Jul 15; 34(7):555-9. PubMed ID: 12170409
    [Abstract] [Full Text] [Related]

  • 4. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
    Kocak Z, Ozkan H, Adli M, Garipagaoglu M, Kurtman C, Cakmak A.
    Radiat Med; 2005 May 15; 23(3):200-7. PubMed ID: 15940068
    [Abstract] [Full Text] [Related]

  • 5. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
    Deodato F, Clemente G, Mattiucci GC, Macchia G, Costamagna G, Giuliante F, Smaniotto D, Luzi S, Valentini V, Mutignani M, Nuzzo G, Cellini N, Morganti AG.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):483-8. PubMed ID: 16242254
    [Abstract] [Full Text] [Related]

  • 6. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma.
    Foo ML, Gunderson LL, Bender CE, Buskirk SJ.
    Int J Radiat Oncol Biol Phys; 1997 Nov 01; 39(4):929-35. PubMed ID: 9369143
    [Abstract] [Full Text] [Related]

  • 7. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
    Isayama H, Tsujino T, Nakai Y, Sasaki T, Nakagawa K, Yamashita H, Aoki T, Koike K.
    World J Gastroenterol; 2012 May 21; 18(19):2364-70. PubMed ID: 22654427
    [Abstract] [Full Text] [Related]

  • 8. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts.
    Shin HS, Seong J, Kim WC, Lee HS, Moon SR, Lee IJ, Lee KK, Park KR, Suh CO, Kim GE.
    Int J Radiat Oncol Biol Phys; 2003 Sep 01; 57(1):105-12. PubMed ID: 12909222
    [Abstract] [Full Text] [Related]

  • 9. Concomitant chemoradiation treatment in the management of patients with extrahepatic biliary tract recurrence of gastric carcinoma.
    Lo SS, Wu CW, Chi KH, Tseng HS, Shen KH, Hsieh MC, Lui WY.
    Cancer; 2000 Jul 01; 89(1):29-34. PubMed ID: 10896997
    [Abstract] [Full Text] [Related]

  • 10. Definitive radiation therapy for extrahepatic bile duct carcinoma.
    Tsujino K, Landry JC, Smith RG, Keller JW, Williams WH, Davis LW.
    Radiology; 1995 Jul 01; 196(1):275-80. PubMed ID: 7784581
    [Abstract] [Full Text] [Related]

  • 11. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy.
    Kamada T, Saitou H, Takamura A, Nojima T, Okushiba SI.
    Int J Radiat Oncol Biol Phys; 1996 Mar 01; 34(4):767-74. PubMed ID: 8598352
    [Abstract] [Full Text] [Related]

  • 12. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
    Mattiucci GC, Autorino R, Tringali A, Perri V, Balducci M, Deodato F, Gambacorta MA, Mantini G, Tagliaferri L, Mutignani M, Morganti AG.
    Brachytherapy; 2015 Mar 01; 14(3):401-4. PubMed ID: 25591935
    [Abstract] [Full Text] [Related]

  • 13. Transduodenal intraluminal high dose rate brachytherapy in the treatment of carcinomas of the subhepatic region.
    Dvorák J, Petera J, Papík Z, Melichar B, Vanásek T, Hulek P, Jandík P, Mergancová J, Zoul Z, Vacek Z.
    Hepatogastroenterology; 2002 Mar 01; 49(46):1045-7. PubMed ID: 12143198
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.
    Ishii H, Furuse J, Nagase M, Kawashima M, Ikeda H, Yoshino M.
    Hepatogastroenterology; 2004 Mar 01; 51(58):954-7. PubMed ID: 15239222
    [Abstract] [Full Text] [Related]

  • 18. Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis.
    Autorino R, Bisiello S, Pappalardi B, Privitera V, Buwenge M, Piccolo F, Masciocchi C, Tagliaferri L, Macchia G, Curti CD, Luppatteli M, Cerrotta A, Morganti AG, Valentini V, Mattiucci G.
    Anticancer Res; 2020 Jun 01; 40(6):3417-3421. PubMed ID: 32487639
    [Abstract] [Full Text] [Related]

  • 19. A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice.
    Xu X, Li J, Wu J, Zhu R, Ji W.
    Cardiovasc Intervent Radiol; 2018 Feb 01; 41(2):206-217. PubMed ID: 29075881
    [Abstract] [Full Text] [Related]

  • 20. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas.
    Dvorák J, Jandík P, Melichar B, Jon B, Mergancová J, Zoul Z, Vacek Z, Petera J.
    Hepatogastroenterology; 2002 Feb 01; 49(46):916-7. PubMed ID: 12143240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.